{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:44:52Z","timestamp":1780058692316,"version":"3.54.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131652","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T18:51:04Z","timestamp":1436208664000},"page":"e0131652","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00868218","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rebecca J.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi D.","family":"Pathirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Guilfoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Roseby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Bredholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Assmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Breakwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haakon","family":"Sjursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/irv.12077","article-title":"Brief literature review for the WHO global influenza research agenda\u2014highly pathogenic avian influenza H5N1 risk in humans","volume":"7","author":"MD Van Kerkhove","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"ref2","unstructured":"WHO. Influenza at the human-animal interface. Summary and assessment as of 2 October 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_October14.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_October14.pdf?ua=1<\/ext-link> 2014."},{"key":"ref3","article-title":"H5N1 vaccines in humans","author":"M Baz","year":"2013","journal-title":"Virus research"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.11.25","article-title":"ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation","volume":"10","author":"K Lovgren Bengtsson","year":"2011","journal-title":"Expert review of vaccines"},{"issue":"45","key":"ref5","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2011.08.042","article-title":"Evaluation of a virosomal H5N1 vaccine formulated with Matrix M adjuvant in a phase I clinical trial","volume":"29","author":"RJ Cox","year":"2011","journal-title":"Vaccine"},{"issue":"52","key":"ref6","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1016\/j.vaccine.2009.09.044","article-title":"Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice","volume":"27","author":"AS Madhun","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/jis330","article-title":"T-helper 1 cells elicited by H5N1 vaccination predict seroprotection","volume":"206","author":"GK Pedersen","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-2659.2011.00256.x","article-title":"Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model","volume":"5","author":"G Pedersen","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3855\/jidc.2666","article-title":"The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development","volume":"6","author":"D Banner","year":"2012","journal-title":"Journal of infection in developing countries"},{"key":"ref10","unstructured":"WHO Expert Committee on Biological Standardization. WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines. Annex 5 2005 [cited 2005 24\u201328 October]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/entity\/vaccine_research\/diseases\/influenza\/ECBS_2005_Annex_5_Influenza.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/entity\/vaccine_research\/diseases\/influenza\/ECBS_2005_Annex_5_Influenza.pdf<\/ext-link>."},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1371\/journal.pone.0004384","article-title":"MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults","volume":"4","author":"A Banzhoff","year":"2009","journal-title":"PloS one"},{"issue":"9272","key":"ref12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"KG Nicholson","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0264-410X(94)90334-4","article-title":"An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination","volume":"12","author":"RJ Cox","year":"1994","journal-title":"Vaccine"},{"issue":"1\u20132","key":"ref14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"S Crotty","year":"2004","journal-title":"Journal of immunological methods"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","article-title":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice","volume":"62","author":"AO Hovden","year":"2005","journal-title":"Scandinavian journal of immunology"},{"key":"ref16","unstructured":"Mahy BWJ KH. Virology methods manual1996."},{"key":"ref17","unstructured":"WHO. Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwwhoint\/influenza\/resources\/documents\/h5n1_laboratory_procedures\/en\/\" xlink:type=\"simple\">http:\/\/wwwwhoint\/influenza\/resources\/documents\/h5n1_laboratory_procedures\/en\/<\/ext-link>."},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/erv.11.48","article-title":"Current adjuvants and new perspectives in vaccine formulation","volume":"10","author":"E Montomoli","year":"2011","journal-title":"Expert review of vaccines"},{"issue":"9587","key":"ref19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"I Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"33","key":"ref20","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2008.05.077","article-title":"Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults","volume":"26","author":"TM Nolan","year":"2008","journal-title":"Vaccine"},{"issue":"15","key":"ref21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMc0805274","article-title":"Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1","volume":"359","author":"I Stephenson","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/CVI.00373-12","article-title":"Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A\/H5N1 prepandemic influenza vaccine in adult and elderly subjects","volume":"19","author":"I Bihari","year":"2012","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"48","key":"ref23","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2013.08.064","article-title":"Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5\/Indonesia\/05\/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant","volume":"31","author":"JJ Treanor","year":"2013","journal-title":"Vaccine"},{"issue":"13","key":"ref24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.4049\/jimmunol.1000911","article-title":"Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells","volume":"185","author":"D Frolich","year":"2010","journal-title":"J Immunol"},{"issue":"13","key":"ref26","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1084\/jem.20110740","article-title":"Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants","volume":"208","author":"WE Purtha","year":"2011","journal-title":"The Journal of experimental medicine"},{"issue":"35","key":"ref27","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1016\/j.vaccine.2014.06.009","article-title":"Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination","volume":"32","author":"GK Pedersen","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/infdis\/jis589","article-title":"A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination","volume":"206","author":"RD Pathirana","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"RJ Cox","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/171.1.198","article-title":"Parenteral influenza vaccination induces a rapid systemic and local immune response","volume":"171","author":"KA Brokstad","year":"1995","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid1407.071681","article-title":"Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1)","volume":"14","year":"2008","journal-title":"Emerging infectious diseases"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1750-2659.2009.00078.x","article-title":"Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses","volume":"3","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","author":"I Leroux-Roels","year":"2008","journal-title":"PloS one"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"I Stephenson","year":"2005","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"B Baras","year":"2008","journal-title":"PloS one"},{"issue":"31","key":"ref36","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1016\/j.vaccine.2009.04.050","article-title":"Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets","volume":"27","author":"HL Forrest","year":"2009","journal-title":"Vaccine"},{"issue":"7101","key":"ref37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"NM Ferguson","year":"2006","journal-title":"Nature"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"e26973","DOI":"10.1371\/journal.pone.0026973","article-title":"Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP","volume":"6","author":"GK Pedersen","year":"2011","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:20:22Z","timestamp":1589037622000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131652"}},"subtitle":[],"editor":[{"given":"T. Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131652","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]}}}